SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene...
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of its Liver.SET™ library of liver-specific synthetic...
Stem cell implants aim to restore dopamine in Parkinson’s disease
Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year. Although available treatments can help manage symptoms, there...
Small molecule targets glioblastoma oncogene in preclinical studies
UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed new treatment for the deadliest brain cancer.
Researcher Hui Li, PhD,...
Australian researchers develop a new way to target deadly, drug-resistant bacteria
Australian researchers have developed a powerful new way to target deadly, drug-resistant bacteria by designing antibodies that recognize a sugar found only on bacterial cells – an advance that could underpin a new generation...
Scientists create new map showing how cancer gene mutations influence tumor growth
Scientists have created a complete map showing how hundreds of possible mutations in a key cancer gene influence tumor growth. The study focused on CTNNB1, a gene that produces the protein β-catenin, which helps...
New platform improves prediction of human antibody drug responses
An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published in Science Immunology,...
Early TB treatment before sepsis diagnosis could save countless lives
Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are diagnosed with...
Twenty-Two Genes Could Hike Risk for Long-Term Health Issues After Epstein-Barr Infection
Researchers from AstraZeneca, Memorial Sloan Kettering Cancer Center, and Baylor College of Medicine have identified 22 genes which increase the risk of developing a range of chronic conditions following an Epstein-Barr Virus (EBV) infection....
Aptamer-based wearables revolutionize continuous health tracking
Continuous monitoring of biomarkers is essential for early disease detection, treatment evaluation, and personalized health management, yet most clinical tests rely on invasive, single-point blood sampling. Recent advances in aptamer-based wearable electrochemical sensors offer...
Immunotherapy Reduces Plaque in Mouse Arteries, Suggesting Coronary Disease Intervention
Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against heart disease. The novel therapy uses a lab-generated antibody to destroy a harmful type...
